Wegovy Pill Legitimacy Examined: 2026 Consumer Analysis Investigates Ro's Oral GLP-1 Access Pathway and No-Insurance Cash-Pay Options As Novo Nordisk launches first FDA-approved oral weight loss medication, independent examination evaluates Ro's direct-to-patient distribution model, pricing transparency, and telehealth access structure for patients exploring Wegovy Pill without insurance GlobeNewswire January 12, 2026 NEW YORK, NY, Jan. […]

Best Electrolyte Supplement Analysis 2026: Seaonic Challenges Top Hydration Packets With Ocean-Sourced Minerals A deep-dive into what's driving the shift toward seawater-derived electrolytes–and how Seaonic's published disclosures compare with common verification criteria GlobeNewswire January 12, 2026 DENVER, CO, Jan. 12, 2026 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only. It is not

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Bitdeer to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in Bitdeer between June 6, 2024 and November 10, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh

Washington, DC, Jan. 12, 2026 (GLOBE NEWSWIRE) — Washington Business Journals has named Brian Ferdinand as one of its 2026 Projected Breakout Traders, recognizing his disciplined approach to markets, long-term vision, and evolving leadership in modern trading. The designation reflects Ferdinand's professional journey across finance, real estate, and hospitality, as well as his recent return

— AbbVie will provide low prices in Medicaid, and expand affordable, direct-to-patient offerings for treatments used by millions of Americans through TrumpRx — AbbVie will commit $100 billion in U.S. research and development (R&D) and capital investments, including manufacturing, over the next decade — This three-year agreement provides AbbVie with exemption from tariffs and future

NEW YORK CITY, NY / ACCESS Newswire / January 12, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Above Foods Ingredients Inc. ("Above Food" or the "Company") (NASDAQ:ABVE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Above Food and certain of

Washington Business Journals Names Brian Ferdinand as a 2026 Projected Breakout Trader GlobeNewswire January 12, 2026 Washington, DC, Jan. 12, 2026 (GLOBE NEWSWIRE) — Washington Business Journals has named Brian Ferdinand as one of its 2026 Projected Breakout Traders, recognizing his disciplined approach to markets, long-term vision, and evolving leadership in modern trading. The designation

(NYSE:GTN),(NYSE:GTN-A), ATLANTA, Jan. 12, 2026 (GLOBE NEWSWIRE) — Gray Media, Inc. (NYSE: GTN) today announced that it will release its earnings results for the quarter ended, December 31, 2025, on Thursday, February 26, 2026. Earnings Conference Call Information Gray Media, Inc. will host a conference call to discuss its operating results for the quarter ended

NEW YORK CITY, NY / ACCESS Newswire / January 12, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Rezolute, Inc. ("Rezolute" or the "Company") (NASDAQ:RZLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Rezolute and certain of its officers and/or directors

GRAY SETS DATE FOR FOURTH QUARTER EARNINGS RELEASE AND EARNINGS CONFERENCE CALL GlobeNewswire January 12, 2026 ATLANTA, Jan. 12, 2026 (GLOBE NEWSWIRE) — Gray Media, Inc. (NYSE: GTN) today announced that it will release its earnings results for the quarter ended, December 31, 2025, on Thursday, February 26, 2026. Earnings Conference Call Information Gray Media,